Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Place of General Medical During Oncology Care Management (MGPEC_Onco)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03416465
Recruitment Status : Recruiting
First Posted : January 31, 2018
Last Update Posted : June 6, 2019
Sponsor:
Information provided by (Responsible Party):
Institut de Cancérologie de Lorraine

Brief Summary:

The Purpose of MGPEC_ONCO is to see if patient consult their general practitioner during the management of their cancer, especially before hospitalization. The study concerns not planned hospitalizations in medicine service.

Before leaving hospital, the patient completes the survey, other data are taken in patient record


Condition or disease Intervention/treatment
Oncologic Disorders Behavioral: medical questionnaire

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Place of General Medical During Oncology Care Management
Actual Study Start Date : May 16, 2018
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020

Intervention Details:
  • Behavioral: medical questionnaire
    The patient will complete a questionnaire of 10 questions before leaving hospital. This questionnaire concerns the care pathway for hospitalized patients.


Primary Outcome Measures :
  1. Patients in unscheduled hospitalization [ Time Frame: 1 day ]
    Percentage of patients in unscheduled hospitalization who have seen their general practitioner



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any patient hospitalized in a medical service in an unscheduled way
Criteria

Inclusion Criteria:

  • Patient undergoing oncology treatment or ≤ 1 year of the latest oncology treatments
  • Patient hospitalized in a medical service in an unscheduled way
  • Age > or = 18 years old
  • Patient informed and not opposed to the study
  • Patient able and agreeing to follow all study procédures
  • Patient must be affiliated to a social security system

Exclusion Criteria:

  • Patient hospitalized in surgery and continuing care services
  • Patient deprived of liberty or under supervision

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03416465


Contacts
Layout table for location contacts
Contact: MERLIN JEAN LOUIS +33 3 83 59 83 07 jl.merlin@nancy.unicancer.fr
Contact: FERNANDES LAURINDA +33 3 83 59 84 87 l.fernandes@nancy.unicancer.fr

Locations
Layout table for location information
France
Institut de Cancérologie de Lorraine Recruiting
Vandœuvre-lès-Nancy, France
Contact: HENRY ALINE, MD    + 33 3 83 59 84 86    a.henry@nancy.unicancer.fr   
Contact: TOMASSO DAMIEN, MD       damientomasso@icloud.com   
Sponsors and Collaborators
Institut de Cancérologie de Lorraine
Investigators
Layout table for investigator information
Principal Investigator: HENRY ALINE Institut de Cancérologie de Lorraine
Layout table for additonal information
Responsible Party: Institut de Cancérologie de Lorraine
ClinicalTrials.gov Identifier: NCT03416465    
Other Study ID Numbers: 2017-A03429-44
First Posted: January 31, 2018    Key Record Dates
Last Update Posted: June 6, 2019
Last Verified: June 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Institut de Cancérologie de Lorraine:
hospitalization
cancer
general practitioner